| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |